Harpoon Therapeutics (HARP) Peer Comparison

$23.01

$0.00 (0.00%)

As on 11-Mar-2024 16:00EDT

Market cap

$492 Mln

Revenue (TTM)

$37 Mln

P/E Ratio

--

P/B Ratio

108.4

Div. Yield

0 %

Edit

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Market cap ($ Mln)	492	769	12,599
Revenue ($ Mln)	37	--	1
Net Profit ($ Mln)	-30.87	-92.62	-433.68
Net Margin (%)	-82.66	--	-3,475.94
RoE (%)	-1,174.47	-42.83	-36.44
Price to Earnings	--	--	--
Price-To-Book	108.42	3.31	10.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Operating Revenue	31.92	0.58	10.64
Cost of Revenue	3.10	1.84	1.11
Gross Profit	31.92	-1.26	10.64
Operating Expenses	100.24	95.06	300.31
Operating Profit (EBIT)	-68.33	-95.06	-289.68
Other Income	-0.02	--	14.76
Profit before Tax	-67.73	-91.76	-274.92
Provision for Tax	-0.59	-3.30	1.42
Profit after Tax (Net Income)	-67.14	-88.46	-276.34
Minority Interest	--	--	--
Consolidated Profit	-67.73	-91.76	-276.34

Liabilities ($ Mln)

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Shareholder's Funds	5.40	218.16	1,126.24
Minority Interest	--	--	--
Non-Current Liabilities	15.90	6.73	3.15
Current Liabilities	52.43	13.79	33.95
Total Liabilities	73.73	238.68	1,163.33

Assets ($ Mln)

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Non-Current Assets	19.00	14.76	8.57
Current Assets	54.73	223.91	1,154.77
Total Assets	73.73	238.68	1,163.33
Total Debt*	16.01	8.80	5.33
Net Current Assets	2.29	210.13	1,120.82

Cashflow ($ Mln)

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Cash From Operating Activities	-89.18	-61.68	-228.01
Cash Flow from Investing Activities	89.74	-1.01	-586.40
Cash from Financing Activities	6.37	10.31	855.78
Net Cash Inflow / Outflow	23.72	--	41.38

Ratios

Profitability Ratios

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
ROCE (%)	-146.49	-35.02	-33.68
ROE (%)	-211.56	-35.64	-33.94
ROA (%)	-58.59	-33.61	-32.68
EBIT Margin (%)	--	--	--
Net Margin (%)	-210.36	-15,198.97	-1,088.15
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Revenue Growth (%)	0.35	-0.93	-0.71
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	59.66	-30.09	-92.16
EPS Growth (%)	0.61	-0.28	-0.74
Book Value Growth (%)	--	--	--

Valuation Ratios

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Price / Earnings	-0.04	-3.57	-22.75
Price / Book Value	0.45	1.45	5.58
Dividend Yield (%)	--	--	--
EV/EBITDA	0.53	-1.13	-17.91
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Debt to Equity	2.96	0.04	0.00
Short term debt to equity ratio	0.45	0.01	0.00
Current Ratio	1.04	16.24	34.02
Quick Ratio	--	--	33.18
Interest Coverage	-115.03	-28.81	-20.43

Operating Efficiency Ratios

	Harpoon Therapeutics (HARP)	Icosavax Inc (ICVX)	Karuna Therapeutics (KRTX)
Debtors to sales (%)	3.64	--	0.54
Asset Turnover	0.28	0.00	0.01
Receivable days	9.84	--	31.02
Inventory Days	--	--	8,081.81
Payable days	435.07	672.93	709.15
Cash Conversion Cycle	--	--	7,403.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly